Bank of New York Mellon Corp lowered its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 13.5% in the ...

Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week ...

After hours: March 17 at 5:55:30 p.m. EDT Loading Chart for TXG ...

Investing.com - 10X Genomics (NASDAQ: TXG) reported second quarter EPS of $-0.53, $0.13 worse than the analyst estimate of $-0.40.

Cathie Wood's ARK ETFs have made a series of trades on Tuesday, April 9, 2024, as part of their regular portfolio adjustments. The ...

PLEASANTON, CA—Alan Mateo, a director at 10x Genomics, Inc. (NASDAQ:TXG), has recently increased his stake in the company.... In a turbulent market environment, 10X Genomics Inc (NASDAQ:TXG) ...